These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 12520711)
1. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Buhr T; Büsche G; Choritz H; Länger F; Kreipe H Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711 [TBL] [Abstract][Full Text] [Related]
2. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients]. Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296 [TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features. Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800 [TBL] [Abstract][Full Text] [Related]
4. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Thiele J; Kvasnicka HM Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727 [TBL] [Abstract][Full Text] [Related]
5. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method. Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478 [TBL] [Abstract][Full Text] [Related]
6. Trisomy 8 in prefibrotic early stages of chronic idiopathic myelofibrosis: a fluorescence in situ study of bone marrow biopsies. Thiele J; Varus E; Kvasnicka HM; Wickenhauser C Acta Haematol; 2006; 115(1-2):97-101. PubMed ID: 16424657 [TBL] [Abstract][Full Text] [Related]
7. [Study of 161 chronic idiopathic myelofibrosis patients for clinicopathological staging]. Liu AN; Chen HS; Liu EB; Fang LH; Yang QY; Qian LS Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):178-82. PubMed ID: 16792920 [TBL] [Abstract][Full Text] [Related]
8. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders. Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853 [TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case]. Uemura Y; Iwahara Y; Kataoka R; Muneishi H; Miyoshi I Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832 [TBL] [Abstract][Full Text] [Related]
11. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis. Thiele J; Kvasnicka HM; Schmitt-Gräff A; Hülsemann R; Diehl V Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl. Thiele J; Kvasnicka HM; Vardiman J Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481 [TBL] [Abstract][Full Text] [Related]
14. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Thiele J; Kvasnicka HM Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946 [TBL] [Abstract][Full Text] [Related]
15. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis. Brousseau M; Parot-Schinkel E; Moles MP; Boyer F; Hunault M; Rousselet MC Histopathology; 2010 May; 56(6):758-67. PubMed ID: 20546341 [TBL] [Abstract][Full Text] [Related]
16. [Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)]. Hernandez Nieto L; Morey Sureda M; Granena A; Montserrat Costa E; Feliu E; Rozman C Nouv Rev Fr Hematol (1978); 1979; 21(3):251-6. PubMed ID: 296376 [TBL] [Abstract][Full Text] [Related]
17. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification. Kvasnicka HM; Thiele J Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877 [TBL] [Abstract][Full Text] [Related]
18. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha]. Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186 [TBL] [Abstract][Full Text] [Related]